Ant venom immunotherapy in Australia: the unmet need. Issue 1 (7th July 2014)

• Record Type: Journal Article
• Authors: Mullins, Raymond J; Brown, Simon G A
• Is Part Of: Medical journal of Australia. Volume 201:Issue 1(2014)
• Page Start: 33
• Page End: 34
• Publication Date: 2014-07-07
• Subjects: Wounds and injuries -- Immune system diseases; Medicine -- Periodicals; Medicine; Médecine -- Périodiques; Medicine; Periodical; Periodicals; Electronic journals; 610
• DOI: 10.5694/mja13.00035
• Languages: English
• ISSNs: 0025-729X

Abstract

Summary: Jack jumper ant (JJA) venom allergy is an important cause of anaphylaxis in south‐eastern Australia. The efficacy and real‐world effectiveness of JJA venom immunotherapy (VIT) to prevent anaphylaxis in allergic patients are now well established, with an evidence base that is at least equivalent to that supporting VIT for allergy to other insect species. The tolerability and safety of JJA VIT are comparable with those of honeybee VIT.